Ultragenyx Pharmaceutical (RARE) Change in Inventory (2018 - 2026)

Ultragenyx Pharmaceutical (RARE) has 9 years of Change in Inventory data on file, last reported at $4.0 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $4.0 million, up 300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (down 8.87% YoY), and the FY2025 annual result was $6.0 million, down 45.45% from the prior year.
• Change in Inventory grew to $4.0 million in Q1 2026 per RARE's latest filing, from -$150000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $5.6 million in Q3 2025 and troughed at -$445000.0 in Q2 2025.
• A 5-year average of $2.2 million and a median of $2.1 million in 2024 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2022 and 2025: Change in Inventory jumped 1782.98% in 2022, then sank 110.78% in 2025.
• A 5-year view of Change in Inventory shows it stood at $4.2 million in 2022, then sank by 51.82% to $2.0 million in 2023, then climbed by 11.01% to $2.2 million in 2024, then plunged by 106.67% to -$150000.0 in 2025, then soared by 2766.67% to $4.0 million in 2026.
• Business Quant data shows RARE's Change in Inventory at $4.0 million in Q1 2026, -$150000.0 in Q4 2025, and $5.6 million in Q3 2025.